Search

Zimmer Biomet Holdings Inc

Закрыт

СекторЗдравоохранение

100.57 1.07

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

98.58

Макс.

101.05

Ключевые показатели

By Trading Economics

Доход

-39M

199M

Продажи

90M

2.2B

P/E

Средняя по отрасли

23.392

57.002

Прибыль на акцию

2.07

Дивидендная доходность

0.99

Рентабельность продаж

9.159

Сотрудники

17,000

EBITDA

-210M

328M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+5.74% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

0.99%

2.22%

Следующий отчет о доходах

4 нояб. 2026 г.

Дата следующей выплаты дивидендов

30 окт. 2026 г.

Следующая эксдивидендная дата

29 сент. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-112M

19B

Предыдущая цена открытия

99.5

Предыдущая цена закрытия

100.57

Новостные настроения

By Acuity

50%

50%

171 / 340 Рейтинг в Healthcare

Zimmer Biomet Holdings Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 авг. 2026 г., 19:46 UTC

Shares of Zimmer Biomet Holdings are trading higher, remaining strong near the upper end of their one-month range amid positive broader market sentiment.

12 авг. 2026 г., 23:21 UTC

Zimmer Biomet Holdings Inc. shares are roughly flat in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 авг. 2026 г., 23:02 UTC

Zimmer Biomet Holdings Inc. shares are higher in after-market trading, moving within a range above its 20-day moving average and near a one-month high.

10 авг. 2026 г., 19:56 UTC

Correlated Moves
News

Canaccord raised Zimmer Biomet's price target to $100 from $83, maintaining a Hold rating. Shares are higher since Friday's close amid market strength.

7 авг. 2026 г., 19:46 UTC

News

Zimmer Biomet shares are lower today as Truist maintains a Hold rating but raises the price target to $106 amid cautious market conditions.

6 авг. 2026 г., 19:52 UTC

News

Zimmer Biomet shares are lower today, despite price target increases from RBC, BMO, and Wells Fargo. This marks a shift from recent higher daily closes.

5 авг. 2026 г., 23:02 UTC

News

Stifel raised the price target on Zimmer Biomet to $110 from $105, maintaining a Buy rating. Shares are higher in after-market trading.

4 авг. 2026 г., 22:01 UTC

Zimmer Biomet Holdings Inc. shares are lower in after-market trading, continuing a trend of weakness despite earlier stability and trading above its 20-day moving average.

3 авг. 2026 г., 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31 июл. 2026 г., 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30 июл. 2026 г., 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29 июл. 2026 г., 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28 июл. 2026 г., 20:03 UTC

News
Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27 июл. 2026 г., 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24 июл. 2026 г., 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23 июл. 2026 г., 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22 июл. 2026 г., 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20 июл. 2026 г., 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Сравнение c конкурентами

Изменение цены

Zimmer Biomet Holdings Inc Прогноз

Целевая цена

By TipRanks

5.74% рост

Прогноз на 12 месяцев

Средняя 105.29 USD  5.74%

Максимум 120 USD

Минимум 93 USD

Основано на мнении 17 аналитиков Wall Street, спрогнозировавших целевые цены для Zimmer Biomet Holdings Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

17 ratings

6

Покупка

11

Удержание

0

Продажа

Настроения

By Acuity

171 / 340Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat